Designing Better Pediatric Medicines for Real-World Patient Needs
A full-day event dedicated to advancing pediatric medicine
This event starts at 9:00 am ET and runs through 5:00 pm ET. In-person event, virtual attendance is unavailable. Questions or trouble registering? Contact events[@]quotientsciences.com.
Event Details
Join us for a full-day event dedicated to advancing pediatric medicine, featuring expert-led sessions and networking opportunities.
Hosted by the Quotient Sciences team, this event brings together leading professionals to discuss key topics in pediatric drug development, including taste and palatability assessments, regulatory considerations, food compatibility, formulation development, and patient acceptability.
You'll hear presentations from renowned speakers, with the opportunity to participate in interactive Q&A sessions and ample time for networking over lunch and a drinks reception at the conclusion of the event.
Whether you’re looking to deepen your expertise, connect with peers, or explore the latest innovations in pediatric science, this event promises valuable insights and engaging discussions.
| Time | Description |
|---|---|
| 09:00 AM – 09:15 AM | Welcome & Introduction Presented by Nazim Kanji (Quotient Sciences) |
| 09:15 AM – 10:00 AM | Trends, Targets, and Expectations for Pediatric New Product Development / Q&A Presented by Daniel Schaufelberger (Schaufelberger Consulting) |
| 10:00 AM – 10:45 AM | Pediatric Regs and Guidelines / Pediatric plans / QTPP / PERA Presented by Mohan Ganapathy (Mohan Pharma CMC Consulting LLC) |
| 10:45 AM – 11:15 AM | Coffee Break |
| 11:15 AM – 12:00 AM | Pediatric Formulation Development and Clinical Assessment / Q&A Presented by Helen Baker (Quotient Sciences) |
| 12:00 AM – 12:45 PM | Patient Considerations for Pediatric Dosage Form Design / Pediatric Acceptability / Q&A Presented by Rachel Meyers (Rutgers University) |
| 12:45 PM – 01:30 PM | Lunch & Networking |
| 01:30 PM – 02:15 PM | Food Compatibility Studies / Q&A Presented by Brad Rowe (Quotient Sciences) |
| 02:15 PM – 03:00 PM | Late-Stage/Commercial Considerations for Pediatric Drug Products Presented by Bob Cornog (Quotient Sciences) |
| 03:00 PM – 05:00 PM | Closing Remarks and Q&A followed by a drinks reception |
Questions or trouble registering? Contact events[@]quotientsciences.com.
Key Learning Objectives
- Trends in pediatric drug development
- Regulatory perspectives in PIP/PSP, pediatric QTPP, and excipient risk assessment
- Formulation development pathways for pediatric products
- Taste and palatability assessment approaches for pediatric dosage forms
- Patient centric design and acceptability in hospital settings
- Food compatibility studies with pediatric dosage forms
- Scale-up process development of pediatric dosage forms
Meet our Experts
-
Brad Rowe
Senior Director, Integrated Development
-
Robert Cornog
Senior Director, Product Development
-
Dr. Helen Baker
Director, Formulation Design, Analytical Development
-
Nazim Kanji
Executive Director, Pediatric Services
-
Daniel Schaufelberger, PhD
Pharmaceutical Executive
-
Rachel Meyers
Clinical Professor
-
Ganapathy Mohan, Ph.D
President, Mohan Pharma CMC Consulting LLC
